Genomics

Dataset Information

0

Identification of differentially expressed miRNAs in PD vs. nonPD in cancer samples


ABSTRACT: Lack of a standard method for stratifying advanced-stage NSCLC patients receiving platinum combination therapy often results in a number of patients that do not derive benefit yet are still exposed to treatment toxicity. We hypothesized that miRNAs in pre-treatment serum and/or plasma could be used to differentiate non-small cell lung cancer (NSCLC) patients who would have disease progression to first-line carboplatin and gemcitabine chemotherapy at first response assessment. miRNA profiling of mature and precursor miRNAs was performed on total RNA isolated from the pre-treatment serum and plasma of 24 NSCLC patients. Single validated candidates or combinations thereof were selected based on specificity and sensitivity to segregate patients with disease progression at first radiologic response (PD) vs. those without progressed disease (nonPD). Two precursor miRNA were significantly over-expressed in serum (but not plasma) of PD patients: pre-miR-518b and pre-miR-598. Serum miRNAs may serve as a screening tool in predicting chemoresistance to platinum-based combination chemotherapy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE25019 | GEO | 2012/12/01

SECONDARY ACCESSION(S): PRJNA134389

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-12-01 | E-GEOD-25019 | biostudies-arrayexpress
2020-07-14 | GSE154286 | GEO
2023-01-12 | GSE189045 | GEO
2015-04-15 | E-GEOD-56036 | biostudies-arrayexpress
2024-03-30 | GSE242860 | GEO
2017-01-10 | GSE93300 | GEO
2017-02-07 | GSE94536 | GEO
2022-05-25 | GSE185546 | GEO
2023-07-11 | BIOMD0000001074 | BioModels
2015-01-13 | E-GEOD-64915 | biostudies-arrayexpress